Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1957 1
1958 2
1962 1
1965 1
1968 1
1969 1
1989 1
1990 8
1992 1
1993 2
1994 3
1995 3
1996 3
1999 1
2000 4
2001 8
2002 4
2003 6
2004 8
2005 3
2006 1
2007 7
2008 8
2009 8
2010 4
2011 7
2012 6
2013 4
2014 5
2015 8
2016 17
2017 5
2018 8
2019 8
2020 8
2021 17
2022 15
2023 15
2024 19
2025 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

217 results

Results by year

Filters applied: . Clear all
Page 1
Nerandomilast in Patients with Progressive Pulmonary Fibrosis.
Maher TM, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Kreuter M, Oldham JM, Richeldi L, Valenzuela C, Wijsenbeek MS, Clerisme-Beaty E, Coeck C, Gu H, Ritter I, Schlosser A, Stowasser S, Voss F, Weimann G, Zoz DF, Martinez FJ; FIBRONEER-ILD Trial Investigators. Maher TM, et al. Among authors: voss f. N Engl J Med. 2025 Jun 12;392(22):2203-2214. doi: 10.1056/NEJMoa2503643. Epub 2025 May 19. N Engl J Med. 2025. PMID: 40388329 Clinical Trial.
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD).
Maher TM, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Kreuter M, Oldham JM, Richeldi L, Valenzuela C, Wijsenbeek MS, Coeck C, Schlecker C, Voss F, Wachtlin D, Martinez FJ. Maher TM, et al. Among authors: voss f. BMJ Open Respir Res. 2023 Sep;10(1):e001580. doi: 10.1136/bmjresp-2022-001580. BMJ Open Respir Res. 2023. PMID: 37709661 Free PMC article. Clinical Trial.
[Anticoagulation after heart valve replacement].
Voss F, Sucker C, Litmathe J. Voss F, et al. Wien Med Wochenschr. 2023 Mar;173(3-4):84-89. doi: 10.1007/s10354-021-00845-7. Epub 2021 May 5. Wien Med Wochenschr. 2023. PMID: 33950320 Review. German.
Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening.
Weiss A, Zapardiel-Gonzalo J, Voss F, Jolink M, Stock J, Haupt F, Kick K, Welzhofer T, Heublein A, Winkler C, Achenbach P, Ziegler AG, Bonifacio E; Fr1da-study group. Weiss A, et al. Among authors: voss f. Diabetologia. 2022 Dec;65(12):2121-2131. doi: 10.1007/s00125-022-05780-9. Epub 2022 Aug 27. Diabetologia. 2022. PMID: 36028774 Free PMC article.
Temporal profiling of M-TEER-related complications.
Haschemi J, Schrameck H, Haurand JM, Oehler D, Spieker M, Voss F, Kelm M, Polzin A, Horn P. Haschemi J, et al. Among authors: voss f. ESC Heart Fail. 2025 Jun;12(3):2107-2112. doi: 10.1002/ehf2.15220. Epub 2025 Jan 26. ESC Heart Fail. 2025. PMID: 39865608 Free PMC article.
Real-world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study.
Nies RJ, Ney S, Kindermann I, Bewarder Y, Zimmer A, Knebel F, Hahn K, Spethmann S, Luedike P, Michel L, Rassaf T, Papathanasiou M, Störk S, Cejka V, Polzin A, Voss F, Kelm M, Unsöld B, Meindl C, Paulus M, Yilmaz A, Chamling B, Morbach C, Pfister R. Nies RJ, et al. Among authors: voss f. ESC Heart Fail. 2025 Apr;12(2):1203-1216. doi: 10.1002/ehf2.15126. Epub 2024 Nov 6. ESC Heart Fail. 2025. PMID: 39505353 Free PMC article.
Multi-dimensional outcomes following extracorporeal cardiopulmonary resuscitation.
Thevathasan T, Wahl V, Boettel J, Kenny M, Paul J, Selzer S, Harbi AA, Dorsch EM, Audebert H, Rose M, Klapproth CP, Lech S, Schmitt K, Desch S, Landmesser U, Westenfeld R, Voss F, Skurk C. Thevathasan T, et al. Among authors: voss f. Resusc Plus. 2025 Jan 30;22:100888. doi: 10.1016/j.resplu.2025.100888. eCollection 2025 Mar. Resusc Plus. 2025. PMID: 40008321 Free PMC article.
Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity.
Moreno-Arciniegas A, García A, Kelm M, D'Amore F, da Silva MG, Sánchez-González J, Sánchez PL, López-Fernández T, Córdoba R, Asteggiano R, Camus V, Smink J, Ferreira A, Kersten MJ, Bolaños N, Escalera N, Pacella E, Gómez-Talavera S, Quesada A, Rosselló X, Ibanez B; RESILIENCE Trial Investigators. Moreno-Arciniegas A, et al. Eur J Heart Fail. 2024 Oct;26(10):2213-2222. doi: 10.1002/ejhf.3395. Epub 2024 Aug 30. Eur J Heart Fail. 2024. PMID: 39212445 Free article.
217 results